Sanara MedTech
SMTI
40 hedge funds and large institutions have $20.6M invested in Sanara MedTech in 2024 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 20 increasing their positions, 10 reducing their positions, and 7 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 10
0.58% more ownership
Funds ownership: 7.88% → 8.46% (+0.58%)
7% less funds holding
Funds holding: 43 → 40 (-3)
18% less capital invested
Capital invested by funds: $25.1M → $20.6M (-$4.53M)
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
+$1.31M |
| 2 |
WIA
World Investment Advisors
Santa Barbara,
California
|
+$814K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$177K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$164K |
| 5 |
Lazard Asset Management
New York
|
+$64.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$297K |
| 2 |
QC
Quadrature Capital
London,
United Kingdom
|
-$244K |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$215K |
| 4 |
Nuveen
Charlotte,
North Carolina
|
-$205K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$82.3K |
SMTI Hedge Fund Activity: Q2 2024 in Review
40 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in Sanara MedTech (SMTI) for Q2 2024, worth a combined $20.6M — down 18% from $25.1M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of SMTI and 4 opened new positions — a net loss of 3 holders — while 10 trimmed existing stakes and 20 added.
The largest buyer was Janney Montgomery Scott, adding an estimated $1.31M. The largest seller was Citadel Advisors, exiting entirely with an estimated $297K sold.
- 40 institutional investors held Sanara MedTech (SMTI) as of Q2 2024, down from 43 in Q1 2024.
- Funds reported $20.6M of Sanara MedTech stock for Q2 2024, down 18% quarter-over-quarter.
- 4 funds opened new Sanara MedTech positions in Q2 2024 and 7 closed out, a net change of -3 holders.
- The largest Sanara MedTech buyer in Q2 2024 was Janney Montgomery Scott, an estimated $1.31M added.
- The largest Sanara MedTech seller in Q2 2024 was Citadel Advisors, an estimated $297K sold.
Based on aggregated 13F filings for Q2 2024.